Anandan PALANI,Xianhai HUANG,Dong XIAO,Sunil PALIWAL,Hon-Chung TSUI,Michelle Laci WROBLESKI,Ashwin U. RAO,Cheng WANG,Sapna S. SHAH,Neng-Yang SHIH
申请号：
US15938409
公开号：
US20180215729A1
申请日:
2018.03.28
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A compound having the general structure shown in Formula I:or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
